Nokia supports diabetes app

  • 9 April 2010

An application has been launched to provide access to the MyGlucoHealth diabetes management system from Nokia mobile phones worldwide.

The application is the result of a partnership between Nokia and Entra Health, which developed the MyGlucoHealth wireless meter and portal.

It allows allows Nokia users to upload and manage blood glucose readings through the portal. They can review and evaluate results on their handset, and also enter weight, exercise and nutritional information.

The application can also notify family, doctors or caregivers when results exceed personally established threshold limits. And users can send and receive secure messages from their physician.

John Hendel, chairman of Entra Health Systems, said: “Distributing the MyGlucoHealth diabetes app via Ovi Store for Nokia users will strengthen our ability to provide more effective mHealth offerings worldwide.

“We believe that MyGlucoHealth together with Nokia handsets offers a unique and far-reaching solution for connecting patients with clinicians, family and caregivers.”

The app has already been test marketed. Within four weeks, it was downloaded 40,000 times by Nokia users in 130 countries.

The MyGlucoHealth Mobile App is available for free from the Ovi Store: www.store.ovi.com.

Links: Entra Health Systems

Nokia

Subscribe to our newsletter

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Sign up

Related News

Prof Stephen Powis confirmed as Rewired 2025 keynote

Prof Stephen Powis confirmed as Rewired 2025 keynote

Professor Sir Stephen Powis, national medical director at NHS England, has been confirmed as the latest keynote speaker for Rewired 2025.
App improves staff access to documents at Mid and South Essex

App improves staff access to documents at Mid and South Essex

Mid and South Essex NHS Foundation Trust is using the MyStaff app to improve staff access to information vital to their patients’ care.
Movers and Shakers news roundup

Movers and Shakers news roundup

Our latest Movers and Shakers roundup includes the abrupt departure of TPP’s long-serving clinical director, Dr John Parry.